Skip to Content
Merck
All Photos(1)

Key Documents

P2939000

Prilocaine

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

(±)-2′-Methyl-2-(propylamino)propionanilide, N-(2-Methylphenyl)-2-(propylamino)propanamide

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C13H20N2O
CAS Number:
Molecular Weight:
220.31
UNSPSC Code:
41116107
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

prilocaine

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

InChI

1S/C13H20N2O/c1-4-9-14-11(3)13(16)15-12-8-6-5-7-10(12)2/h5-8,11,14H,4,9H2,1-3H3,(H,15,16)

InChI key

MVFGUOIZUNYYSO-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Prilocaine EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Hazard Classifications

Acute Tox. 4 Oral - Eye Irrit. 2

Storage Class Code

11 - Combustible Solids

WGK

WGK 3


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 1

1 of 1

M Y Hyun et al.
Clinical and experimental dermatology, 40(2), 129-135 (2014-10-17)
Hyaluronic acid (HA) fillers and poly-L-lactic acid (PLA) fillers are frequently used to correct facial wrinkles. To compare the efficacy and safety of a novel injectable poly-L-lactic acid (PLA) filler and a well-studied biphasic HA filler for the treatment of
Hee Jung Lee et al.
The Journal of dermatological treatment, 26(1), 73-77 (2014-02-12)
Intense focused ultrasound (IFUS) has been used successfully for skin tightening. To investigate the efficacy of IFUS in treating enlarged pores and to evaluate changes in skin elasticity and sebum production following IFUS. Twenty-two subjects with enlarged pores were randomized
Elena I Gubanova et al.
Journal of drugs in dermatology : JDD, 14(3), 288-298 (2015-03-05)
In this evaluator-blind, placebo-controlled study, microinjections of stabilized hyaluronic acid (HA) gel for rejuvenation of aging hands were evaluated. Patients received three injections of 1.0 ml HA gel (20 mg/ml HA) in the dorsum of one hand and 1.0 ml
Murad Alam et al.
JAMA dermatology, 150(8), 844-849 (2014-06-13)
Neocollagenesis can be achieved using a dermal rolling needle device, thereby reducing the appearance of acne scars. To determine the efficacy of a needling device for treatment of acne scars. We performed a single-center, rater-blinded, balanced (1:1), split-face, placebo-controlled, parallel-group
Adam Rish
Journal of cosmetic dermatology, 13(4), 253-260 (2014-11-18)
A review of 242 facial treatments, in 86 different patients, with polyacrylamide gel (PAAG) was carried out by the author between 2003 and 2013. To evaluate by retrospective study the long-term outcomes of PAAG filling for facial contouring. To quantify

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service